Leclanche SA (LECN)
SIX Swiss Exchange · Switzerland · prices in CHF · close of 27 Oct 2026
Key indicators
| Last close | CHF 0.095 |
|---|---|
| 52-week range | 0.075 – 0.190 |
| Return, 1 month / 3 months | +12.6% / +12.6% |
| Return, 1 year / 3 years | −47.2% / −78.2% |
| Trend | Below its 200-day average |
| RSI (14) | 80 |
| Volatility (1 year) | 70.2% |
| Worst drawdown (1 year) | -56.1% |
| Average daily value traded | 0.00M CHF |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Leclanché SA is a Swiss battery company based in Yverdon-les-Bains that designs and manufactures lithium-ion battery cells, modules and complete energy storage systems. It supplies electrified transport applications such as buses and marine vessels, and it provides stationary storage systems for electricity grids and industrial customers. The company also offers related engineering and integration services, working with transport operators, shipbuilders and energy providers who need rechargeable power systems for vehicles, vessels and fixed installations.
The shares are listed on the SIX Swiss Exchange in Switzerland under the code LECN, and the price on this page is in Swiss francs (CHF). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Leclanche SA (LECN) trades on the SIX Swiss Exchange in Switzerland. It last closed at CHF 0.095 on 27 October 2026.
Its price-based Market X-Ray is 16 out of 100 (a weak price profile), ranking 213 of 226 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 47.2% and over the last three months it rose 12.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on SIX Swiss Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 15 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -4.0% | ||
| From 52-week high | -49.9% | ||
| Momentum | 35 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 12.6% | ||
| 6-month return | -9.5% | ||
| 12-month return, skipping the last month | -53.1% | ||
| Stability (higher is calmer) | 8 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 70.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -56.1% | ||
| Liquidity | 1 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M CHF | ||
| Zero-volume days | 100.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +12.6% |
|---|---|
| 1 month | +12.6% |
| 3 months | +12.6% |
| 6 months | −9.5% |
| 1 year | −47.2% |
| 3 years | −78.2% |
| 5 years | −87.1% |
Signals
| 50-day / 200-day average | 0.085 / 0.099 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.007 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on SIX Swiss Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.